Activation of the PI3K/Akt pathway and chemotherapeutic resistance
- 14 December 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (6) , 234-248
- https://doi.org/10.1016/s1368-7646(02)00120-6
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Living with Lethal PIP3 Levels: Viability of Flies Lacking PTEN Restored by a PH Domain Mutation in Akt/PKBScience, 2002
- Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)Oncogene, 2002
- Differential Modulation of Signaling Pathways and Apoptosis of ras-Transformed 10T1/2 Cells by the Depsipeptide FR901228The Journal of Pharmacology and Experimental Therapeutics, 2002
- Inhibition of protein kinase B/AktPharmacology & Therapeutics, 2002
- Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growthAnnals of Oncology, 2002
- Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic miceCell Death & Differentiation, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor κb Activation, and Bcl-XL Levels in VivoThe Journal of Experimental Medicine, 2000
- D-21266, a new heterocyclic alkylphospholipid with antitumour activityEuropean Journal Of Cancer, 1997
- Role of Phosphatidylinositol-3-Kinase in Insulin Receptor Signaling: Studies with Inhibitor, LY294002Biochemical and Biophysical Research Communications, 1994